Assets, Current of Vitro Biopharma, Inc. from 31 Oct 2010 to 31 Oct 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Vitro Biopharma, Inc. quarterly Assets, Current in USD history and change rate from 31 Oct 2010 to 31 Oct 2025.
Vitro Biopharma, Inc. Assets, Current for the quarter ending 31 Oct 2025 was $862,103, a 12% decline year-over-year.
Source SEC data: View on sec.gov

Assets, Current, Quarterly (USD)

Assets, Current, YoY Quarterly Change (%)

Vitro Biopharma, Inc. Quarterly Assets, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$862,103	-$113,650	-12%	31 Oct 2025	10-K	13 Feb 2026	2025	FY
Q2 2025	$645,413	-$1,286,500	-67%	31 Jul 2025	10-Q	12 Sep 2025	2025	Q3
Q1 2025	$597,319	-$1,524,897	-72%	30 Apr 2025	10-Q	20 Jun 2025	2025	Q2
Q4 2024	$409,390	-$1,882,551	-82%	31 Jan 2025	10-Q	20 Mar 2025	2025	Q1
Q3 2024	$975,753	-$2,203,601	-69%	31 Oct 2024	10-K	13 Feb 2026	2025	FY
Q2 2024	$1,931,913	-$1,375,525	-42%	31 Jul 2024	10-Q	16 Sep 2024	2024	Q3
Q1 2024	$2,122,216	-$521,410	-20%	30 Apr 2024	10-Q	31 May 2024	2024	Q2
Q4 2023	$2,291,941	-$261,350	-10%	31 Jan 2024	10-Q	14 Mar 2024	2024	Q1
Q3 2023	$3,179,354	+$243,213	+8.3%	31 Oct 2023	10-K	28 Jan 2025	2024	FY
Q2 2023	$3,307,438			31 Jul 2023	10-Q	28 Aug 2023	2023	Q3
Q1 2023	$2,643,626			30 Apr 2023	10-Q	13 Jun 2023	2023	Q2
Q4 2022	$2,553,291			31 Jan 2023	10-Q	14 Mar 2023	2023	Q1
Q3 2022	$2,936,141			31 Oct 2022	10-K	29 Jan 2024	2023	FY
Q3 2015	$49,265	+$2,540	+5.4%	31 Oct 2015	10-K	22 Sep 2016	2015	FY
Q2 2015	$53,318	+$12,157	+30%	31 Jul 2015	10-Q	30 Mar 2016	2015	Q3
Q1 2015	$48,643	-$6,431	-12%	30 Apr 2015	10-Q	22 Jan 2016	2015	Q2
Q4 2014	$38,420	-$17,399	-31%	31 Jan 2015	10-Q	24 Mar 2015	2015	Q1
Q3 2014	$46,725	+$13,569	+41%	31 Oct 2014	10-K	22 Sep 2016	2015	FY
Q2 2014	$41,161	+$7,867	+24%	31 Jul 2014	10-Q	22 Sep 2014	2014	Q3
Q1 2014	$55,074	+$26,586	+93%	30 Apr 2014	10-Q	19 Jun 2014	2014	Q2
Q4 2013	$55,819	+$22,596	+68%	31 Jan 2014	10-Q	17 Mar 2014	2014	Q1
Q3 2013	$33,156	-$3,496	-9.5%	31 Oct 2013	10-K	13 Feb 2015	2014	FY
Q2 2013	$33,294	-$928	-2.7%	31 Jul 2013	10-Q	23 Sep 2013	2013	Q3
Q1 2013	$28,488	+$4,980	+21%	30 Apr 2013	10-Q	18 Jun 2013	2013	Q2
Q4 2012	$33,223	+$10,731	+48%	31 Jan 2013	10-Q	21 Mar 2013	2013	Q1
Q3 2012	$36,652	+$12,862	+54%	31 Oct 2012	10-K	12 Feb 2014	2013	FY
Q2 2012	$34,222	+$8,280	+32%	31 Jul 2012	10-Q/A	17 Oct 2012	2012	Q3
Q1 2012	$23,508			30 Apr 2012	10-Q/A	22 Jun 2012	2012	Q2
Q4 2011	$22,492			31 Jan 2012	10-Q	21 Mar 2012	2012	Q1
Q3 2011	$23,790	-$14,286	-38%	31 Oct 2011	10-K	12 Feb 2013	2012	FY
Q2 2011	$25,942			31 Jul 2011	10-Q/A	12 Oct 2011	2011	Q3
Q3 2010	$38,076			31 Oct 2010	10-K/A	16 Feb 2012	2011	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.